Doctor profile · Federal record
Dr. Parmatma Greeley, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Doylestown, PA
- NPI 1457564445
- Accepts Medicare
- MIPS 64.2 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
103 Progress Dr, Ste 300
Doylestown, PA 189012511
(215) 447-3630
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- October 22, 2019
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Pennsylvania #MD430764
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457564445. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,252
Distinct HCPCS
10
Medicare allowed
$414,425
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,780 | 40 | $23 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 1,007 | 683 | $186 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 674 | 550 | $132 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 456 | 242 | $35 | |
76536 |
Ultrasound scan of head and neck soft tissue | 101 | 97 | $117 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 71 | 71 | $173 | |
96372 |
Injection of drug or substance under skin or into muscle | 66 | 41 | $15 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 45 | 37 | $93 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 40 | 38 | $94 | |
99441 |
Telephone medical discussion with physician, 5-10 minutes | 12 | 12 | $58 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 441. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$413
Transactions
25
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 13 | $157.69 | |
| Medtronic, Inc. | 2 | $50.42 | |
| Amgen Inc. | 2 | $47.31 | |
| Tandem Diabetes Care, Inc. | 2 | $33.92 | |
| ABBVIE INC. | 2 | $33.73 | |
| Insulet Corporation | 1 | $29.83 | |
| BETA BIONICS, INC. | 1 | $23.99 | |
| Novo Nordisk Inc | 1 | $18.06 | |
| Tolmar, Inc. | 1 | $17.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,840
Patients
802
Total drug cost
$1,485,357
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 613 | 175 | $10,330 |
| Synthroid (Levothyroxine Sodium) | Brand | 367 | 94 | $39,454 |
| Metformin Hcl | Generic | 246 | 75 | $3,123 |
| Jardiance (Empagliflozin) | Brand | 213 | 47 | $253,259 |
| Novolog Flexpen (Insulin Aspart) | Brand | 195 | 69 | $315,417 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 183 | 59 | $134,623 |
| Ozempic (Semaglutide) | Brand | 154 | 31 | $238,652 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 123 | 35 | $159,105 |
| Methimazole | Generic | 122 | 38 | $2,050 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 121 | 50 | $19,069 |
Hospital affiliations
Frequently asked questions
What is Dr. Parmatma Greeley's medical specialty?
Dr. Parmatma Greeley practices Endocrinology, Diabetes & Metabolism Physician in Doylestown, PA.
Where does Dr. Parmatma Greeley practice?
Dr. Parmatma Greeley practices at 103 Progress Dr, Doylestown, PA 189012511. Office phone: 2154473630.
What is Dr. Parmatma Greeley's NPI?
Dr. Parmatma Greeley's National Provider Identifier (NPI) is 1457564445, issued by NPPES.
Does Dr. Parmatma Greeley accept Medicare assignment?
Yes. Dr. Parmatma Greeley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Parmatma Greeley commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.